SVB Securities analyst Research Report) on August 9 and set a price target of $3.00. The company’s shares closed yesterday at $3.07.
According to TipRanks, Mayo is a 5-star analyst with an average return of 9.8% and a 57.80% success rate. Mayo covers the Healthcare sector, focusing on stocks such as Universal Health, Amedisys, and Tenet Healthcare.
In addition to SVB Securities, Clover Health Investments also received a Hold from Citigroup’s Jason Cassorla in a report issued on August 9. However, on the same day, Credit Suisse maintained a Sell rating on Clover Health Investments (NASDAQ: CLOV).
See today’s best-performing stocks on TipRanks >>
CLOV market cap is currently $1.32B and has a P/E ratio of (3.25).
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients.
Read More on CLOV:
- Analysts Offer Insights on Healthcare Companies: Reata Pharmaceuticals (RETA), Turning Point Therapeutics (TPTX) and Talkspace (TALK)
- SVB Securities Sticks to Their Hold Rating for scPharmaceuticals (SCPH)
- SVB Securities Keeps Their Buy Rating on NeoGenomics (NEO)
- SVB Securities Remains a Buy on MannKind (MNKD)
- SVB Securities Reaffirms Their Hold Rating on Recursion Pharmaceuticals (RXRX)
